SNWV•CMS cut 2027 Medicare reimbursement for Sanuwave Health’s Ultramist in physician offices and mobile clinics by about 21% to $314.54 per treatment, from $397.81 in 2026. Hospital outpatient reimbursement rises about 15% to $235.04.
CMS cut 2027 Medicare reimbursement for Ultramist in physician offices and mobile clinics by about 21% to $314.54 per treatment, while the hospital outpatient rate rises about 15% to $235.04. A phased reduction in practice expense inputs is expected to drive a significant further cut in 2028 absent further rulemaking; Sanuwave disputes CMS’s cost assumptions and is evaluating response options.
